Literature DB >> 9405027

Immunodetection of G proteins in human pituitary adenomas: evidence for a low expression of proteins of the Gi subfamily.

E Ballaré1, S Mantovani, M Bassetti, A Lania, A Spada.   

Abstract

G proteins mediate signal transduction in a variety of cell systems. As the expression of these proteins has not yet been investigated in detail in human pituitary tumors, we evaluated the presence of G proteins in a series of tumors including six non-functioning adenomas, five GH-secreting adenomas, three prolactinomas and one TSH-secreting adenoma, using immunoblotting and immunohistochemistry. By immunoblotting, Gi1/2alpha was undetectable in six and barely detectable in nine tumors. A similar pattern of expression was observed by probing with the antibody to Gi3alpha, which detected a very weak band in 11 tumors and no protein in four. In contrast, using large amounts of membrane proteins (40 microg), both Gi1/2alpha and Gi3alpha were detected, although at very low levels, in the negative tumors. The low expression of these proteins appeared to be specific to tumoral tissues, as both Gi1/2alpha and Gi3alpha were abundant in normal human and rat pituitary. In all tumors, Go alpha, the two Gs alpha forms, Gq/11 and G beta were present in significant amounts. Semiquantitative analysis indicated that Gs alpha was clearly detected when 2.5 microg loaded proteins were used, whereas Gi1/2alpha and Gi3alpha were barely detected with 5 microg. By immunofluorescence, all tumors studied were markedly positive for Gs alpha that was immunolocalized at the cell periphery, whereas they showed a weak positivity for Gi1/2alpha and Gi3alpha. The study is the first to provide evidence for a low expression of Gi proteins, which are involved in the transduction of inhibitory signals, in pituitary adenomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405027     DOI: 10.1530/eje.0.1370482

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  5 in total

Review 1.  Somatostatin receptor ligands in acromegaly: clinical response and factors predicting resistance.

Authors:  Rosa Maria Paragliola; Salvatore Maria Corsello; Roberto Salvatori
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

Review 2.  Drug resistance in pituitary tumours: from cell membrane to intracellular signalling.

Authors:  Erika Peverelli; Donatella Treppiedi; Federica Mangili; Rosa Catalano; Anna Spada; Giovanna Mantovani
Journal:  Nat Rev Endocrinol       Date:  2021-06-30       Impact factor: 43.330

3.  Alteration in G proteins and prolactin levels in pituitary after ethanol and estrogen treatment.

Authors:  Kirti Chaturvedi; Dipak K Sarkar
Journal:  Alcohol Clin Exp Res       Date:  2008-03-11       Impact factor: 3.455

4.  Non-functioning pituitary adenomas infrequently harbor G-protein gene mutations.

Authors:  R M Ruggeri; L Santarpia; L Curtò; M L Torre; M Galatioto; S Galatioto; F Trimarchi; S Cannavò
Journal:  J Endocrinol Invest       Date:  2008-11       Impact factor: 4.256

Review 5.  Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement.

Authors:  Erika Peverelli; Donatella Treppiedi; Elena Giardino; Eleonora Vitali; Andrea G Lania; Giovanna Mantovani
Journal:  Front Endocrinol (Lausanne)       Date:  2015-12-22       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.